Development Level

Tbio 172 | 11,445
Tdark 68 | 6,588
Tclin 12 | 613
Tchem 7 | 1,598

IMPC Phenotype

increased lean body mass 3 | 172
decreased circulating glucose ... 2 | 126
decreased total body fat amoun... 2 | 207
increased mean corpuscular hem... 2 | 36
abnormal QT variability 1 | 10
abnormal embryo size 1 | 220
abnormal femur morphology 1 | 14
abnormal pelvic girdle bone mo... 1 | 12
abnormal retina morphology 1 | 71
abnormal seminal vesicle morph... 1 | 114
abnormal skin morphology 1 | 50
abnormal sleep behavior 1 | 70
aorta dilation 1 | 3
decreased cardiac muscle contr... 1 | 11
decreased circulating calcium ... 1 | 36
decreased circulating choleste... 1 | 93
decreased circulating magnesiu... 1 | 13
decreased lean body mass 1 | 135
decreased mature B cell number 1 | 7
decreased monocyte cell number 1 | 8
decreased vertical activity 1 | 208
dilated heart left ventricle 1 | 11
embryonic growth retardation 1 | 106
embryonic lethality prior to o... 1 | 239
embryonic lethality prior to t... 1 | 278
hydrometra 1 | 53
hyperactivity 1 | 148
hypoactivity 1 | 132
increased bone mineral content 1 | 108
increased bone mineral density 1 | 72
increased circulating sodium l... 1 | 71
increased grip strength 1 | 41
increased heart weight 1 | 62
increased lymphocyte cell numb... 1 | 32
increased spleen weight 1 | 10
increased total body fat amoun... 1 | 134
increased vertical activity 1 | 24
preweaning lethality, incomple... 1 | 499
prolonged PR interval 1 | 15
prolonged QRS complex duration 1 | 8
prolonged QT interval 1 | 38
small superior vagus ganglion 1 | 74

Disease

Cancer 121 | 2,499
psoriasis 115 | 6,694
Carcinoma 94 | 11,493
osteosarcoma 80 | 7,950
diabetes mellitus 78 | 1,728
Ankylosing spondylitis 75 | 140
Hypersensitivity reaction type II disease 73 | 253
Behcet's disease 72 | 89
Arthritis 65 | 290
tuberculosis 65 | 2,010
Acquired immunodeficiency syndrome 62 | 197
Human immunodeficiency virus infectious disease 61 | 138
Uveitis 60 | 103
lung cancer 60 | 4,740
Herpes zoster 57 | 68
Juvenile rheumatoid arthritis 57 | 111
Rheumatoid arthritis 53 | 1,191
Psoriatic arthritis 51 | 86
dermatomyositis 51 | 966
lung carcinoma 51 | 2,843
Stevens-Johnson syndrome 50 | 92
interstitial cystitis 50 | 2,312
cutaneous lupus erythematosus 49 | 1,057
glioblastoma 48 | 5,792
ovarian cancer 43 | 8,520
Dermatitis 42 | 157
non-small cell lung cancer 39 | 2,890
Synovitis 38 | 78
Multiple Sclerosis 37 | 540
Takayasu's arteritis 36 | 53
Behcet's syndrome 35 | 50
Congenital adrenal hyperplasia 35 | 73
Nephritis 35 | 51
Retinal vasculitis 35 | 36
Spondyloarthropathy, Susceptibility To, 1 35 | 35
drug-induced hepatitis 35 | 44
ulcerative colitis 34 | 1,819
Kidney disease 33 | 430
lung adenocarcinoma 33 | 2,716
Anemia 32 | 365
Astrocytoma, Pilocytic 32 | 3,081
adult high grade glioma 32 | 3,801
invasive ductal carcinoma 29 | 2,951
medulloblastoma, large-cell 29 | 6,241
Liver disease 28 | 237
Skin disease 26 | 66
atypical teratoid / rhabdoid tumor 26 | 5,112
intraductal papillary-mucinous carcinoma (IPMC) 25 | 2,989
primary Sjogren syndrome 25 | 735
Hepatitis B 24 | 108
Leprosy 24 | 73
Primary immunodeficiency disease 24 | 54
subependymal giant cell astrocytoma 24 | 2,287
Hemochromatosis 23 | 54
ependymoma 23 | 4,679
intraductal papillary-mucinous adenoma (IPMA) 23 | 2,955
Autosomal recessive predisposition 22 | 1,442
malignant mesothelioma 22 | 3,232
Birdshot chorioretinopathy 21 | 23
periodontitis 21 | 293
group 3 medulloblastoma 20 | 4,104
pancreatic cancer 20 | 2,398
juvenile dermatomyositis 19 | 1,187
Breast cancer 18 | 3,578
Liver Cirrhosis, Experimental 18 | 769
Multiple myeloma 16 | 1,332
breast carcinoma 16 | 1,638
intraductal papillary-mucinous neoplasm (IPMN) 16 | 3,291
Human immunodeficiency virus type 1, susceptibility to 15 | 26
Pre-Eclampsia 15 | 68
mucosa-associated lymphoid tissue lymphoma 15 | 484
pituitary cancer 15 | 1,972
Asthma 14 | 385
Psoriasis susceptibility 1 14 | 14
Schizophrenia 14 | 1,160
head and neck cancer and chronic obstructive pulmonary disease 14 | 239
primitive neuroectodermal tumor 14 | 3,035
Duchenne muscular dystrophy 13 | 601
Kidney cancer 13 | 2,613
ductal carcinoma in situ 13 | 1,745
Immunologic Deficiency Syndromes 12 | 113
astrocytic glioma 12 | 2,597
cystic fibrosis 12 | 1,696
gastric carcinoma 12 | 807
astrocytoma 11 | 1,146
chronic lymphosyte leukemia 11 | 204
pancreatic ductal adenocarcinoma liver metastasis 11 | 1,962
primary pancreatic ductal adenocarcinoma 11 | 1,109
Crohn's disease 10 | 321
active Crohn's disease 10 | 922
colon cancer 10 | 1,478
nasopharyngeal carcinoma 10 | 1,058
oligodendroglioma 10 | 2,850
sarcoidosis 10 | 370
Inflammatory bowel disease 9 | 151
Lung disease 9 | 142
Malaria 9 | 160
Pneumonia 9 | 174
esophageal adenocarcinoma 9 | 737
group 4 medulloblastoma 9 | 1,855

Tissue

Blood and immune system 115 | 16,909
Digestive Tract 113 | 17,369
Endocrine System 112 | 18,159
Respiratory system 112 | 16,393
Female tissues 111 | 17,400
Liver and Pancreas 111 | 16,750
Urinary Tract 110 | 16,678
Skin and soft tissues 109 | 17,230
Male tissues 108 | 17,142
Nervous System 103 | 16,725
Cardiovascular System 100 | 15,192

Target Family

Non-IDG 252 | 12,091
Enzyme 4 | 4,145
Transcription Factor 3 | 1,400

GO Process

regulation of immune response 259 | 259
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
HLA class I histocompatibility antigen, B-35 alpha chain HLA-B Tbio Non-IDG -1.88752 1613.5 0
Leukocyte-associated immunoglobulin-like receptor 1 LAIR1 Tbio Non-IDG -1.74760 64.2 487
Natural cytotoxicity triggering receptor 2 NCR2 Tbio Non-IDG -2.05295 100.7 196
CD40 ligand CD40LG Tbio Non-IDG -4.58203 37578.3 1461
Immunoglobulin kappa variable 3-11 IGKV3-11 Tdark Non-IDG 0.00000 0
T-cell receptor beta chain V region CTL-L17 TCRB Tdark Non-IDG 0.00000 0
CD276 antigen CD276 Tbio Non-IDG -3.03140 785.5 481
Cytotoxic and regulatory T-cell molecule CRTAM Tbio Non-IDG -1.11760 15.6 131
Killer cell immunoglobulin-like receptor 2DL4 KIR2DL4 Tbio Non-IDG -1.87668 75.1 222
Immunoglobulin kappa variable 1D-39 IGKV1D-39 Tdark Non-IDG 0.00000 0